Showing results (11-20 of 79) with videos related to
Sort By:
Pageof 8
Hematological Oncology|March 1, 1992
The biological and clinical significance of the KI-67 growth fraction in multiple myelomaJ Drach, C Gattringer, H Glassl, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1992
Regulation of the expression of ICAM-1 on human monocytes and monocytic tumor cell linesJ Möst, W Schwaeble, J Drach, et al.Cancer Research|May 1, 1993
Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acidJ Drach, G Lopez-Berestein, T McQueen, et al.Leukemia & Lymphoma|February 1, 1995
Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesisJ Drach, S Zhao, D Drach, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphomaS Wöhrer, A Püspök, J Drach, et al.Neoplasma|June 27, 2018
Serum and urinary levels of CD222 in cancer: origin and diagnostic valueK Vicikova, E Petrovcikova, P Manka, et al.Leukemia & Lymphoma|June 1, 1993
Immunoglobulin gene rearrangement in plasma cell dyscrasias: detection of small clonal cell populations in peripheral blood and bone marrowF Fend, K Weyrer, J Drach, et al.Journal of Cancer Research and Clinical Oncology|August 29, 2000
The biology of multiple myelomaJ Drach, H Kaufmann, E Urbauer, et al.Cytometry|November 1, 1989
Simultaneous flow cytometric analysis of surface markers and nuclear Ki-67 antigen in leukemia and lymphomaJ Drach, C Gattringer, H Glassl, et al.Clinical and Experimental Rheumatology|March 15, 2002
Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myelomaT Bachleitner-Hofmann, K Machold, R Knobler, et al.Pageof 8